PEG-L-ASP: administration form
Item
PEG-L-ASP administration form p.i. (2h)
boolean
C0071568 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
PEG-L-ASP: dosage
Item
PEG-L-ASP dosage 2500 E/mˆ2/ED (ONCASPAR: 3750 E/ED)
float
C0071568 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
PEG-L-ASP: date of administration
Item
PEG-L-ASP (First dose of PEG-L-ASP in Phase IB: 14 days after last dose in Phase IIA. No delay because of uncomplicated myelosupression or coagulopathy) Date of administration
date
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
CPM: administration form
Item
Cyclophosphamide administration form p.i. (1h) (+ MESNA)
boolean
C0010583 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
CPM: dosage
Item
Cyclophosphamide 1000 mg/mˆ2/ED
float
C0010583 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
CPM: date of administration
Item
Cyclophosphamide Date of administration
date
C0010583 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
ARA-C: administration form
Item
ARA-C administration form i.v.
boolean
C0010711 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
ARA-C: dosage
Item
ARA-C dosage 75 mg/mˆ2/ED
float
C0010711 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
ARA-C: date of administration
Item
ARA-C Date of administration
date
C0010711 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
TG: administration form
Item
Thioguanine administration form p.o. (14d)
boolean
C0039902 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
TG: dosage
Item
Thioguanine dosage 60 mg/mˆ2/d
float
C0039902 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
TG: start date
Item
Thioguanine Start date of therapy
date
C0039902 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
TG: end date
Item
Thioguanine End date of therapy
date
C0039902 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
MTX: administration form
Item
MTX administration form i.th
boolean
C0025677 (UMLS CUI [1,1])
C0677897 (UMLS CUI [1,2])
MTX: dosage
Item
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
float
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
MTX: date of administration
Item
MTX Date of administration
date
C0025677 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
PEG-L-ASP discontinuation
Item
Discontinuation of PEG-L-ASP therapy in this element?
boolean
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
PEG-L-ASP: date of last administration
Item
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
date
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
Item
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
text
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
CL Item
allergic reaction to PEG-L-ASP (allergic reaction to PEG-L-ASP)
CL Item
DVT or SVT (DVT or SVT)
CL Item
Pancreatitis (Pancreatitis)
CL Item
Insulin-dependent hyperglycaemia (Insulin-dependent hyperglycaemia)
CL Item
other medical reason (other medical reason)
CL Item
other non-medical reason (other non-medical reason)
Reason for discontinuation of PEG-L-ASP therapy: specification
Item
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation: If other medical or non-medical reason, specify:
text
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Hospital nights
Item
Number of Nights in Hospital (Day 36 until start of maintenance treatment)
float
C0420496 (UMLS CUI [1])
Chemotherapy creator: signature
Item
Date and signature of the doctor who calculated and created chemotherapy regimen
text
C0392920 (UMLS CUI [1,1])
C1707531 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Chemotherapy administration: signature
Item
Date and signature of the person who administered chemotherapy
text
C0392920 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])